← FDA Drug Approvals (Drugs@FDA)

XIIDRA

NDA · New Drug Application · Sponsor: BAUSCH AND LOMB INC · Approved 2016-07-11

Drug application

FDA Application #

NDA208073

Application type

New Drug Application

Brand name

XIIDRA

Generic name

LIFITEGRAST

Active ingredients

LIFITEGRAST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

BAUSCH AND LOMB INC

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2016-07-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown